rs13292454

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000136.3(FANCC):​c.345+7856C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0509 in 152,270 control chromosomes in the GnomAD database, including 275 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.051 ( 275 hom., cov: 32)

Consequence

FANCC
NM_000136.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.241

Publications

7 publications found
Variant links:
Genes affected
FANCC (HGNC:3584): (FA complementation group C) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
FANCC Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • colorectal cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0797 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000136.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCC
NM_000136.3
MANE Select
c.345+7856C>T
intron
N/ANP_000127.2Q00597
FANCC
NM_001243743.2
c.345+7856C>T
intron
N/ANP_001230672.1A0A024R9N2
FANCC
NM_001243744.2
c.345+7856C>T
intron
N/ANP_001230673.1A0A087WW44

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCC
ENST00000289081.8
TSL:1 MANE Select
c.345+7856C>T
intron
N/AENSP00000289081.3Q00597
FANCC
ENST00000375305.6
TSL:1
c.345+7856C>T
intron
N/AENSP00000364454.1Q00597
FANCC
ENST00000490972.7
TSL:1
c.345+7856C>T
intron
N/AENSP00000479931.1A0A087WW44

Frequencies

GnomAD3 genomes
AF:
0.0509
AC:
7740
AN:
152152
Hom.:
274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0124
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0832
Gnomad ASJ
AF:
0.0412
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0271
Gnomad FIN
AF:
0.0783
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0698
Gnomad OTH
AF:
0.0430
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0509
AC:
7748
AN:
152270
Hom.:
275
Cov.:
32
AF XY:
0.0505
AC XY:
3762
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0123
AC:
511
AN:
41558
American (AMR)
AF:
0.0835
AC:
1278
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0412
AC:
143
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5178
South Asian (SAS)
AF:
0.0278
AC:
134
AN:
4828
European-Finnish (FIN)
AF:
0.0783
AC:
830
AN:
10602
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0698
AC:
4745
AN:
68008
Other (OTH)
AF:
0.0426
AC:
90
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
371
742
1114
1485
1856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0642
Hom.:
678
Bravo
AF:
0.0498
Asia WGS
AF:
0.0150
AC:
51
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.75
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13292454; hg19: chr9-97995075; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.